Radiological and histological findings of an asymptomatic ever-increasing neoplasm: The small bowel neuroendocrine tumor (NET)

Dasari, 2017, Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States, JAMA Oncol, 3, 1335, 10.1001/jamaoncol.2017.0589 Yao, 2008, One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumours in 35,825 cases in the United States, J Clin Oncol, 26, 3063, 10.1200/JCO.2007.15.4377 Cingam, 2017 Abu-Hamda, 2003, Small bowel tumours, Curr Gastroenterol Rep, 5, 386, 10.1007/s11894-003-0051-5 Niederle, 2016, ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum, Neuroendocrinology, 103, 125, 10.1159/000443170 Park, 2013, Primary mesenteric carcinoid tumour, J Korean Surg Soc, 84, 114, 10.4174/jkss.2013.84.2.114 Rozenblum, 2019, The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI, Abdom Radiol (NY), 7, 2474, 10.1007/s00261-019-01994-5 Nilica, 2016, Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle, Eur J Nucl Med Mol Imaging, 43, 1585, 10.1007/s00259-016-3328-2